Global Hospital-Acquired Infection (HAI) Diagnostic Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size 2017-2028

2.1.2 Hospital-Acquired Infection (HAI) Diagnostic Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Hospital-Acquired Infection (HAI) Diagnostic Segment by Type

2.2.1 Molecular Diagnostics

2.2.2 Blood Tests

2.2.3 Urinalysis

2.3 Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type

2.3.1 Hospital-Acquired Infection (HAI) Diagnostic Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type (2017-2022)

2.4 Hospital-Acquired Infection (HAI) Diagnostic Segment by Application

2.4.1 Urinary Tract Infections

2.4.2 Pneumonia

2.4.3 Surgical Site Infections

2.4.4 Bloodstream Infections

2.4.5 Other Hospital Infections

2.5 Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application

2.5.1 Hospital-Acquired Infection (HAI) Diagnostic Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application (2017-2022)

3 Hospital-Acquired Infection (HAI) Diagnostic Market Size by Player

3.1 Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Players

3.1.1 Global Hospital-Acquired Infection (HAI) Diagnostic Revenue by Players (2020-2022)

3.1.2 Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share by Players (2020-2022)

3.2 Global Hospital-Acquired Infection (HAI) Diagnostic Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Hospital-Acquired Infection (HAI) Diagnostic by Regions

4.1 Hospital-Acquired Infection (HAI) Diagnostic Market Size by Regions (2017-2022)

4.2 Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth (2017-2022)

4.3 APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth (2017-2022)

4.4 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth (2017-2022)

4.5 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth (2017-2022)

5 Americas

5.1 Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2017-2022)

5.2 Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2017-2022)

5.3 Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size by Region (2017-2022)

6.2 APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2017-2022)

6.3 APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Hospital-Acquired Infection (HAI) Diagnostic by Country (2017-2022)

7.2 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2017-2022)

7.3 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic by Region (2017-2022)

8.2 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2017-2022)

8.3 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.1 Global Hospital-Acquired Infection (HAI) Diagnostic Forecast by Regions (2023-2028)

10.1.1 Global Hospital-Acquired Infection (HAI) Diagnostic Forecast by Regions (2023-2028)

10.1.2 Americas Hospital-Acquired Infection (HAI) Diagnostic Forecast

10.1.3 APAC Hospital-Acquired Infection (HAI) Diagnostic Forecast

10.1.4 Europe Hospital-Acquired Infection (HAI) Diagnostic Forecast

10.1.5 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Forecast

10.2 Americas Hospital-Acquired Infection (HAI) Diagnostic Forecast by Country (2023-2028)

10.2.1 United States Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.2.2 Canada Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.2.3 Mexico Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.2.4 Brazil Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.3 APAC Hospital-Acquired Infection (HAI) Diagnostic Forecast by Region (2023-2028)

10.3.1 China Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.3.2 Japan Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.3.3 Korea Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.3.4 Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.3.5 India Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.3.6 Australia Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.4 Europe Hospital-Acquired Infection (HAI) Diagnostic Forecast by Country (2023-2028)

10.4.1 Germany Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.4.2 France Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.4.3 UK Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.4.4 Italy Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.4.5 Russia Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.5 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Forecast by Region (2023-2028)

10.5.1 Egypt Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.5.2 South Africa Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.5.3 Israel Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.5.4 Turkey Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.5.5 GCC Countries Hospital-Acquired Infection (HAI) Diagnostic Market Forecast

10.6 Global Hospital-Acquired Infection (HAI) Diagnostic Forecast by Type (2023-2028)

10.7 Global Hospital-Acquired Infection (HAI) Diagnostic Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 bioMérieux

11.1.1 bioMérieux Company Information

11.1.2 bioMérieux Hospital-Acquired Infection (HAI) Diagnostic Product Offered

11.1.3 bioMérieux Hospital-Acquired Infection (HAI) Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 bioMérieux Main Business Overview

11.1.5 bioMérieux Latest Developments

11.2 Abbott Laboratories

11.2.1 Abbott Laboratories Company Information

11.2.2 Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Product Offered

11.2.3 Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Abbott Laboratories Main Business Overview

11.2.5 Abbott Laboratories Latest Developments

11.3 Alere, Inc.

11.3.1 Alere, Inc. Company Information

11.3.2 Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offered

11.3.3 Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Alere, Inc. Main Business Overview

11.3.5 Alere, Inc. Latest Developments

11.4 Roche

11.4.1 Roche Company Information

11.4.2 Roche Hospital-Acquired Infection (HAI) Diagnostic Product Offered

11.4.3 Roche Hospital-Acquired Infection (HAI) Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Roche Main Business Overview

11.4.5 Roche Latest Developments

11.5 Siemens Healthcare

11.5.1 Siemens Healthcare Company Information

11.5.2 Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Product Offered

11.5.3 Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Siemens Healthcare Main Business Overview

11.5.5 Siemens Healthcare Latest Developments

11.6 Becton Dickenson

11.6.1 Becton Dickenson Company Information

11.6.2 Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Product Offered

11.6.3 Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Becton Dickenson Main Business Overview

11.6.5 Becton Dickenson Latest Developments

11.7 Cepheid Inc.

11.7.1 Cepheid Inc. Company Information

11.7.2 Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offered

11.7.3 Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Cepheid Inc. Main Business Overview

11.7.5 Cepheid Inc. Latest Developments

11.8 Thermo Fisher Scientific

11.8.1 Thermo Fisher Scientific Company Information

11.8.2 Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Product Offered

11.8.3 Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Thermo Fisher Scientific Main Business Overview

11.8.5 Thermo Fisher Scientific Latest Developments

11.9 Seegene, Inc.

11.9.1 Seegene, Inc. Company Information

11.9.2 Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offered

11.9.3 Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Seegene, Inc. Main Business Overview

11.9.5 Seegene, Inc. Latest Developments

11.10 Qiagen

11.10.1 Qiagen Company Information

11.10.2 Qiagen Hospital-Acquired Infection (HAI) Diagnostic Product Offered

11.10.3 Qiagen Hospital-Acquired Infection (HAI) Diagnostic Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Qiagen Main Business Overview

11.10.5 Qiagen Latest Developments

12 Research Findings and Conclusion

Table 1. Hospital-Acquired Infection (HAI) Diagnostic Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Molecular Diagnostics

Table 3. Major Players of Blood Tests

Table 4. Major Players of Urinalysis

Table 5. Hospital-Acquired Infection (HAI) Diagnostic Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type (2017-2022)

Table 8. Hospital-Acquired Infection (HAI) Diagnostic Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application (2017-2022)

Table 11. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share by Player (2020-2022)

Table 13. Hospital-Acquired Infection (HAI) Diagnostic Key Players Head office and Products Offered

Table 14. Hospital-Acquired Infection (HAI) Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Regions (2017-2022)

Table 19. Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Country (2017-2022)

Table 21. Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type (2017-2022)

Table 23. Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application (2017-2022)

Table 25. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Region (2017-2022)

Table 27. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type (2017-2022)

Table 29. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application (2017-2022)

Table 31. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Country (2017-2022)

Table 33. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type (2017-2022)

Table 35. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of Hospital-Acquired Infection (HAI) Diagnostic

Table 44. Key Market Challenges & Risks of Hospital-Acquired Infection (HAI) Diagnostic

Table 45. Key Industry Trends of Hospital-Acquired Infection (HAI) Diagnostic

Table 46. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share Forecast by Application (2023-2028)

Table 52. bioMérieux Details, Company Type, Hospital-Acquired Infection (HAI) Diagnostic Area Served and Its Competitors

Table 53. bioMérieux Hospital-Acquired Infection (HAI) Diagnostic Product Offered

Table 54. bioMérieux Hospital-Acquired Infection (HAI) Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. bioMérieux Main Business

Table 56. bioMérieux Latest Developments

Table 57. Abbott Laboratories Details, Company Type, Hospital-Acquired Infection (HAI) Diagnostic Area Served and Its Competitors

Table 58. Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Product Offered

Table 59. Abbott Laboratories Main Business

Table 60. Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Abbott Laboratories Latest Developments

Table 62. Alere, Inc. Details, Company Type, Hospital-Acquired Infection (HAI) Diagnostic Area Served and Its Competitors

Table 63. Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offered

Table 64. Alere, Inc. Main Business

Table 65. Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Alere, Inc. Latest Developments

Table 67. Roche Details, Company Type, Hospital-Acquired Infection (HAI) Diagnostic Area Served and Its Competitors

Table 68. Roche Hospital-Acquired Infection (HAI) Diagnostic Product Offered

Table 69. Roche Main Business

Table 70. Roche Hospital-Acquired Infection (HAI) Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Roche Latest Developments

Table 72. Siemens Healthcare Details, Company Type, Hospital-Acquired Infection (HAI) Diagnostic Area Served and Its Competitors

Table 73. Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Product Offered

Table 74. Siemens Healthcare Main Business

Table 75. Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Siemens Healthcare Latest Developments

Table 77. Becton Dickenson Details, Company Type, Hospital-Acquired Infection (HAI) Diagnostic Area Served and Its Competitors

Table 78. Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Product Offered

Table 79. Becton Dickenson Main Business

Table 80. Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Becton Dickenson Latest Developments

Table 82. Cepheid Inc. Details, Company Type, Hospital-Acquired Infection (HAI) Diagnostic Area Served and Its Competitors

Table 83. Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offered

Table 84. Cepheid Inc. Main Business

Table 85. Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Cepheid Inc. Latest Developments

Table 87. Thermo Fisher Scientific Details, Company Type, Hospital-Acquired Infection (HAI) Diagnostic Area Served and Its Competitors

Table 88. Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Product Offered

Table 89. Thermo Fisher Scientific Main Business

Table 90. Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Thermo Fisher Scientific Latest Developments

Table 92. Seegene, Inc. Details, Company Type, Hospital-Acquired Infection (HAI) Diagnostic Area Served and Its Competitors

Table 93. Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offered

Table 94. Seegene, Inc. Main Business

Table 95. Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Seegene, Inc. Latest Developments

Table 97. Qiagen Details, Company Type, Hospital-Acquired Infection (HAI) Diagnostic Area Served and Its Competitors

Table 98. Qiagen Hospital-Acquired Infection (HAI) Diagnostic Product Offered

Table 99. Qiagen Main Business

Table 100. Qiagen Hospital-Acquired Infection (HAI) Diagnostic Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Qiagen Latest Developments

List of Figures

Figure 1. Hospital-Acquired Infection (HAI) Diagnostic Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type in 2021

Figure 7. Hospital-Acquired Infection (HAI) Diagnostic in Urinary Tract Infections

Figure 8. Global Hospital-Acquired Infection (HAI) Diagnostic Market: Urinary Tract Infections (2017-2022) & ($ Millions)

Figure 9. Hospital-Acquired Infection (HAI) Diagnostic in Pneumonia

Figure 10. Global Hospital-Acquired Infection (HAI) Diagnostic Market: Pneumonia (2017-2022) & ($ Millions)

Figure 11. Hospital-Acquired Infection (HAI) Diagnostic in Surgical Site Infections

Figure 12. Global Hospital-Acquired Infection (HAI) Diagnostic Market: Surgical Site Infections (2017-2022) & ($ Millions)

Figure 13. Hospital-Acquired Infection (HAI) Diagnostic in Bloodstream Infections

Figure 14. Global Hospital-Acquired Infection (HAI) Diagnostic Market: Bloodstream Infections (2017-2022) & ($ Millions)

Figure 15. Hospital-Acquired Infection (HAI) Diagnostic in Other Hospital Infections

Figure 16. Global Hospital-Acquired Infection (HAI) Diagnostic Market: Other Hospital Infections (2017-2022) & ($ Millions)

Figure 17. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application in 2021

Figure 18. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share by Player in 2021

Figure 19. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Regions (2017-2022)

Figure 20. Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size 2017-2022 ($ Millions)

Figure 21. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size 2017-2022 ($ Millions)

Figure 22. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size 2017-2022 ($ Millions)

Figure 24. Americas Hospital-Acquired Infection (HAI) Diagnostic Value Market Share by Country in 2021

Figure 25. Americas Hospital-Acquired Infection (HAI) Diagnostic Consumption Market Share by Type in 2021

Figure 26. Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application in 2021

Figure 27. United States Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Region in 2021

Figure 32. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application in 2021

Figure 33. China Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 37. India Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Country in 2021

Figure 40. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type in 2021

Figure 41. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application in 2021

Figure 42. Germany Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 43. France Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size Market Share by Application in 2021

Figure 50. Egypt Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 56. APAC Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 57. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 59. United States Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 60. Canada Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 61. Mexico Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 62. Brazil Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 63. China Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 64. Japan Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 65. Korea Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 67. India Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 68. Australia Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 69. Germany Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 70. France Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 71. UK Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 72. Italy Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 73. Russia Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 74. Spain Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 75. Egypt Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 76. South Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 77. Israel Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 78. Turkey Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries Hospital-Acquired Infection (HAI) Diagnostic Market Size 2023-2028 ($ Millions)